Cerenome, Inc. (CNSY) Stock Ticker
CNSY right now
Market factors today
Unlock the full CNSY picture
About Cerenome, Inc.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
CNSY stock facts
| Ticker symbol | CNSY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $13.7M |
| CEO | Marc H. Hedrick |
| Employees | 28 |
| Headquarters | Houston, TX, US |
| IPO date | 2026-08-03 |
| Website | www.plustherapeutics.com |
What you can see for CNSY on Tickr
Live CNSY price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CNSY report.
Rankings
FAQ
What is the ticker symbol for Cerenome, Inc.?
The ticker symbol for Cerenome, Inc. is CNSY, listed on the NASDAQ.
What is CNSY?
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.